Global Pain Management Drugs and Devices Market Share, Size, Estimates, Trends and Forecast 2023 - Reuters


Global Pain Management Drugs and Devices Market Share, Size, Estimates, Trends and Forecast 2023

Global Pain Management Drugs and Devices Market Share, Size, Estimates, Trends and Forecast 2023

Mon Jan 22, 2018 - 07:00am UTC

According to Stratistics MRC, the Global Pain Management Drugs and Devices Market is accounted for $41.73 billion in 2016 and is expected to reach $61.52 billion by 2023 growing at a CAGR of 5.7% during the forecast period.

Gaithersburg, Maryland, United States – January 22, 2018

Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

Request for sample here:

Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation. Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a power source and pulse generator, which generates required electrical impulses. North America is anticipated to hold the largest market share due to the rising incidence of chronic diseases, increasing government support, growing middle-class population and disposable income levels in this region.

Access the complete report at:

Some of the key players in the Pain Management Drugs and Devices Market include Abbott Laboratories, Endo International, Abbvie, DJO Global Inc., Johnson & Johnson, Novartis International AG, Grunenthal Gmbh, ELI Lilly & Co, Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Astrazeneca Plc, Purdue Pharma LP, Glaxosmithkline, Medtronic and Boston Scientific Corp.

Make an inquiry at:

Device Types Covered:
• Neuromodulation Devices
• Analgesic Infusion Pumps
• Ablation Devices
• Electrical stimulation devices

Drug Classes Covered:
• Non-Narcotic Analgesics
• Narcotic Pain Management
• Opioids
• Antidepressent
• Anesthetics
• Anticovulsants
• Anti-Migraine Agents
• Other Drug Classes

Applications Covered:
• General Pain
• Dental Pain
• Migraine Pain
• Orthopedic/Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Fibromyalgia Pain
• Surgical Pain
• Other Applications

Indications Covered:
• Arthritic Pain
• Chronic back pain

Mode of Purchases Covered:
• Over-the-counter Devices
• Over-the-counter Devices

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Follow us on Twitter:

Follow us on LinkedIn at:

About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd

This content is produced independently of Reuters Editorial News. For content inquiry, please contact

For content enquiry, please reach us at

Latest News >

Vietnamese PE Mekong Capital completes exit from MobileWorld

The Vietnamese private equity firm exits MobileWorld with an IRR of 61 percent.

09:21am UTC

PetroVietnam to divest 30% from energy subsidiary PV Gas

PetroVietnam looks to sell 30% of its stake in PV Gas to a strategic partner within the next 2 years.

07:58am UTC

Naluri raises US$258k seed round from BioMark, 500 Startups

Naluri Hidup is a business-to-business platform that connects employees with health psychologists, in an effort to promote the journey towards a healthy lifestyle.

07:20am UTC

Vertex Ventures to lead US$5.1 million Series A in Malaysian Retail Solutions Startup StoreHub

StoreHub will use the funding for talent acquisition, product development, and expansion across Southeast Asia

04:59am UTC

Thai Beverage firm Malee to acquire 65% stake in Vietnamese Long Quan Safe Food

Malee regional expansion continues with Vietnam acquisition.

09:01am UTC